accountSeveral pharmaceutical companies are actively growing pipelines of their own in China, although at present the cumulative R&D expenditure of all Chinese pharma businesses amount to less than the spent of a single multinational corporation (MNC) in the West.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to China's Innovative Pharma Landscape: Companies Currently Conducting R&D in China
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account